UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

UBC - March 18, 2013
Patients living with hereditary angioedema (HAE) need to be prepared with an appropriate treatment plan. HAE is a very rare and potentially life threatening genetic condition that occurs in 1 in 10,000 to 1 in 50,000 people. Symptoms...
, Director, Business Development - March 14, 2013
The unknown impact of Healthcare Reform is a hot topic for most manufacturers today.  As we all scramble to prepare for multiple scenarios in uncharted territory, expert guidance is no longer considered a luxury.  To...
UBC - March 14, 2013
When our Patient Assistance Programs (PAP) began 25 years ago, they were among the first in the market.  That’s 25 years of working with pharmaceutical manufacturers to make sure their products are available to eligible patients...
UBC - March 06, 2013
Recently we announced the expansion of our Risk Management Services in Europe.  Janine Collins, M.D., has joined UBC and is leading our European Risk Management activities and Medical Safety.  As we knew she would, she’s hit...
UBC - March 05, 2013
Today, Express Scripts released its 2012 Drug Trend Report, based on Express Scripts claims data for 100 million Americans.  Of special interest to UBC's manufacturer customers, is the information provided on specialty...

Pages